Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors | Zendy

Erik Ingelsson | Zendy; Michael J. Pencina | Zendy; Geoffrey H. Tofler | Zendy; Emelia J. Benjamin | Zendy; Katherine J. Lanier | Zendy; Paul F. Jacques | Zendy; Caroline S. Fox | Zendy; James B. Meigs | Zendy; Daniel Levy | Zendy; Martin G. Larson | Zendy; Jacob Selhub | Zendy; Ralph B. D’Agostino | Zendy; Thomas J. Wang | Zendy; Ramachandran S. Vasan | Zendy

Open Access

Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors

Author(s) -

Erik Ingelsson,

Michael J. Pencina,

Geoffrey H. Tofler,

Emelia J. Benjamin,

Katherine J. Lanier,

Paul F. Jacques,

Caroline S. Fox,

James B. Meigs,

Daniel Levy,

Martin G. Larson,

Jacob Selhub,

Ralph B. D’Agostino,

Thomas J. Wang,

Ramachandran S. Vasan

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.708537

Subject(s) - medicine , metabolic syndrome , endocrinology , aldosterone , plasminogen activator , blood pressure , plasminogen activator inhibitor 1 , natriuretic peptide , biomarker , fibrinogen , cardiology , heart failure , obesity , biochemistry , chemistry

The metabolic syndrome (MetS) is associated with increased cardiovascular risk. We evaluated the relative contributions of circulating biomarkers representing distinct biological pathways to the incidence of MetS and to longitudinal changes of its constituent risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research